DCGI Issues Alert On Suspected Falsified GLP-1-RA Products In The Market
New Delhi : The Central drug regulator has issued alert on suspected falsified versions of Glucagon-like peptide 1 receptor agonist (GLP-1-RA) products, an anti-diabetes management drug, in the market. The alert…
WS DETAILS NCB Seizes 2,724 Kg Of Tablets For Medicinal Use Between 2020 To 2022
New Delhi : The Narcotic Control Bureau (NCB) has seized a total of 2,724 kilogram of tablets having medicinal use in the three years from 2020 to 2022 under the…